Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals

References

• Arslanoglu I, Saka N, Bundak R, et al. A comparison of the use of premixed insulins in pen-injectors with conventional patient-mixed insulin treatment in children and adolescents with IDDM. Is there a decreased risk of night hypoglycemia? J Pediatr Endocrinol Metab 2000;13:313–18
   PubMed Web of Science ®Google Scholar
• Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049–67
   PubMed Web of Science ®Google Scholar
• Asakura T, Seino H, Nakano R, et al. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther 2009;11:657–61
   PubMed Web of Science ®Google Scholar
• Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients’ fears and hopes about insulin therapy. The basis for patient reluctance. Diabetes Care 1997;20:292–8
   PubMed Web of Science ®Google Scholar
• Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract 1995;41:169–73
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):89–100
   PubMed Web of Science ®Google Scholar
• Pfützner A. FlexPen® for the delivery of insulin: recent developments in accuracy, injection force and patient preference. Exp Opin Med Dev 2009;6:115–23
   PubMed Web of Science ®Google Scholar
• Reimer T, Hohberg C, Pfützner AH, et al. Instruction time, intuitiveness and patient acceptance of a prefilled and a re-usable insulin delivery device – the NovoMix® 30 FlexPen® and the HumaPen® Luxura™. Clin Ther 2009;30:2252–62
   Web of Science ®Google Scholar
• Pfützner A, Reimer T, Hohberg C, et al. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:254–9
   Web of Science ®Google Scholar
• Asakura T. Comparison of clinically relevant technical attributes of five insulin injection pens. J Diabetes Sci Technol 2011;5:1203–9
   PubMedGoogle Scholar
• Lee LJ, Li Q, Reynolds MW, et al. Trend analyses of insulin delivery systems in the United States. J Diabetes Sci Technol 2011;5:1116–23
   PubMedGoogle Scholar
• Kesson CM, Bailie BR. Do diabetic patients inject accurate doses of insulin? Diabetes Care 1981;4:333
   PubMed Web of Science ®Google Scholar
• Puxty JA, Hunter DA, Burr WA. Accuracy of insulin injection in elderly patients. Br Med J (Clin Res Ed) 1983;287:1762
   PubMed Web of Science ®Google Scholar
• Niskanen L, Jensen LE, Råstam J, et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes. Clin Therapeut 2004;26:531–40
   PubMed Web of Science ®Google Scholar
• Luijf YM, DeVries JH. Dosing accuracy of insulin pens versus conventional syringes and vials. Diabetes Technol Ther 2010;12(Suppl 1):S73–7
   PubMed Web of Science ®Google Scholar
• Ignaut DA, Schwartz SL, Sarwat S, Murphy HL. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. Diabetes Educ 2009;35:789–98
   PubMed Web of Science ®Google Scholar
• Clarke A, Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv 2007;4:165–74
   PubMed Web of Science ®Google Scholar
• Asche CV, Shane-McWhorter L, Raparla S. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence. Diabetes Technol Ther 2010;12(Suppl 1):S101–8
   PubMed Web of Science ®Google Scholar
• Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712–25
   PubMed Web of Science ®Google Scholar
• Baser O, Bouchard J, DeLuzio T, et al. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe. Adv Ther 2010;27:94–104
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430–2
   PubMed Web of Science ®Google Scholar
• Pfützner J, Hellhammer J, Musholt PB, et al. Evaluation of dexterity, in patients with insulin treated type 1 and type 2 diabetes mellitus. J Diabetes Sci Technol 2011;5:158–65
   PubMedGoogle Scholar
• Pfützner A, Musholt PB, Schipper C, et al. Self-assessment and objective determination of dexterity and cognitive function in patients with type 1 and type 2 diabetes mellitus. Curr Med Res Opin 2012;28:15–21
   PubMed Web of Science ®Google Scholar
• Pfützner A, Schipper C, Niemeyer M, et al. Comparison of patients’ preference for two insulin injection pen devices in relation to patient dexterity skills. J Diabetes Sci Technol 2012;6:910–16
   PubMedGoogle Scholar
• Schipper C, Musholt PB, Niemeyer M, et al. Patient device assessment evaluation for FlexTouch vs. InnoLet in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus. Curr Med Res Opin 2012;28:1297–303
   PubMed Web of Science ®Google Scholar
• Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third party managed care claims data. Clin Ther 2006;28:1712–25
   PubMed Web of Science ®Google Scholar
• Davis EM, Bebee A, Crawford L, et al. Nurse satisfaction using insulin pens in hospitalized patients. Diabetes Educator 2009;35:799–809
   PubMed Web of Science ®Google Scholar